4//SEC Filing
van Dijk Marcus Antonius 4
Accession 0000950170-24-005561
CIK 0001840229other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 8:00 PM ET
Size
7.9 KB
Accession
0000950170-24-005561
Insider Transaction Report
Form 4
van Dijk Marcus Antonius
Chief Technology Officer
Transactions
- Award
Stock Option
2024-01-16+171,078→ 171,078 totalExercise: $0.87Exp: 2034-01-16→ Common Stock (171,078 underlying) - Award
Stock Option
2024-01-16+15,000→ 15,000 totalExercise: $0.87Exp: 2034-01-16→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]An option to purchase Common Stock was granted to Dr. van Dijk on January 16, 2024 and awarded in accordance with the MiNK Therapeutics, Inc. 2021 Equity Incentive Plan. The option vests over a three-year period, with one-third of the options vesting on the one-year anniversary of the grant date, with the remainder vesting in equal quarterly installments thereafter.
- [F2]An option to purchase Common Stock was granted to Dr. van Dijk on January 16, 2024 for his performance in 2023, and awarded in accordance with the MiNK Therapeutics, Inc. 2021 Equity Incentive Plan. Half of the options will vest on June 27, 2024 and half of the options will vest on September 27, 2024.
Documents
Issuer
MiNK Therapeutics, Inc.
CIK 0001840229
Entity typeother
Related Parties
1- filerCIK 0001881659
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 8:00 PM ET
- Size
- 7.9 KB